NCT02195947View on ClinicalTrials.gov

Antagonist Protocol in Poor Responders

PHASE4CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Female Infertility Due to Diminished Ovarian Reserve
Interventions
DRUG

Growth Hormone

Growth hormone (Norditropin, Novo nordisk) was administrated on day 6 of HMG stimulation daily in a dose of 2.5 mg S.C. till the day of hCG administration.

Trial Locations (1)

Unknown

Kasr Al Aini, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02195947 - Antagonist Protocol in Poor Responders | Biotech Hunter | Biotech Hunter